Opinion: The ‘smart pill’ for schizophrenia and bipolar disorder raises tricky ethical questions
The first smart pill that can track if it's been taken is for treating mental illness. Guidelines need to be put in place so it is used ethically.
by Tia P. Powell
Dec 05, 2017
3 minutes
“Smart pills” that can track whether or when you’ve taken your medication might be helpful for some people. Unfortunately, the first smart pill approved by the Food and Drug Administration, Abilify MyCite, is a drug used to treat schizophrenia and bipolar disorder. That raises tricky ethical issues.
Decades of research and clinical experience support the fact that not taking medicines as prescribed across all domains of medicine. Smart pills might help people
You’re reading a preview, subscribe to read more.
Start your free 30 days